stockportfolio.pro
Stocks / A vs IDXX
A vs IDXX
Agilent Technologies, Inc. and IDEXX Laboratories, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Agilent Technologies, Inc. (A) | IDEXX Laboratories, Inc. (IDXX) | |
|---|---|---|
| Market cap | $36.9B | $45.0B |
| Revenue (latest FY) | $6.95B | $4.30B |
| Net income (latest FY) | $1.30B | $1.06B |
| Revenue growth (5y CAGR) | 5.4% | 9.7% |
| Net margin | 18.8% | 24.6% |
| Return on equity | 19.3% | 66.0% |
| P/E ratio | 26.1 | 42.0 |
| Dividend yield | 0.8% | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open A — free Open IDXX — freeFrequently asked questions
Which is bigger, A or IDXX?
IDEXX Laboratories, Inc. is larger by market capitalization — $45.0B versus $36.9B.
Which grows faster, A or IDXX?
Over the last five fiscal years, IDEXX Laboratories, Inc. grew revenue faster — 9.7%/yr versus 5.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.